CTMX icon

CytomX Therapeutics

122 hedge funds and large institutions have $698M invested in CytomX Therapeutics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

55% less call options, than puts

Call options by funds: $724K | Put options by funds: $1.62M

59% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 34

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$724K
Puts
$1.62M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$125M
2
$75.6M
3
$71.6M
4
$49.2M
5
$46.3M
6
$36.7M
7
$28.1M
8
$24.6M
9
$16.5M
10
$13.5M
11
$12.5M
12
$11.4M
13
$10.4M
14
$10M
15
$9.75M
16
$9.51M
17
$8.44M
18
$8.26M
19
$7.26M
20
$6.17M
21
$5.78M
22
$4.9M
23
$4.31M
24
$4.15M
25
$4.02M